Search for other papers by T P Parikh in
Google Scholar
PubMed
Search for other papers by B Stolze in
Google Scholar
PubMed
Search for other papers by Y Ozarda in
Google Scholar
PubMed
Search for other papers by J Jonklaas in
Google Scholar
PubMed
Search for other papers by K Welsh in
Google Scholar
PubMed
Search for other papers by L Masika in
Google Scholar
PubMed
Search for other papers by M Hill in
Google Scholar
PubMed
Search for other papers by A DeCherney in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Department of Medicine, Georgetown University, Washington, District of Columbia, USA
Search for other papers by S J Soldin in
Google Scholar
PubMed
Introduction Diurnal variations in the serum concentration of steroid hormones and their metabolism, as assessed by urinary excretion, have long been known for cortisol and testosterone ( 1 , 2 , 3 ). Less information exists for the other up
Inserm U1016-CNRS UMR8104, Paris, France
Hormonology Department, Cochin Hospital, Paris, France
Search for other papers by Fidéline Bonnet-Serrano in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Radiology Department, Cochin Hospital, Paris, France
Search for other papers by Maxime Barat in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Anna Vaczlavik in
Google Scholar
PubMed
Search for other papers by Anne Jouinot in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Lucas Bouys in
Google Scholar
PubMed
Hormonology Department, Cochin Hospital, Paris, France
INSERM, Physiopathologie et Pharmacotoxicologie Placentaire Humaine : Microbiote Pré & Post natal, Paris, France
Search for other papers by Christelle Laguillier-Morizot in
Google Scholar
PubMed
Search for other papers by Corinne Zientek in
Google Scholar
PubMed
Search for other papers by Catherine Simonneau in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Diabetology Department, Cochin Hospital, Paris, France
Search for other papers by Etienne Larger in
Google Scholar
PubMed
Search for other papers by Laurence Guignat in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Hormonology Department, Cochin Hospital, Paris, France
INSERM, Physiopathologie et Pharmacotoxicologie Placentaire Humaine : Microbiote Pré & Post natal, Paris, France
Search for other papers by Jean Guibourdenche in
Google Scholar
PubMed
UR 7537 BioSTM, Paris, France
Search for other papers by Ioannis Nicolis in
Google Scholar
PubMed
Search for other papers by Marie-Claude Menet in
Google Scholar
PubMed
Inserm U1016-CNRS UMR8104, Paris, France
Reference Center for Rare Adrenal Diseases, Endocrinology Department, Cochin Hospital, Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
-24 stimulation test is not only used to make the diagnosis of adrenal insufficiency, characterized by an insufficient response of cortisol, but is also very useful to detect partial enzymatic deficiency, characterized by an explosive response of the steroid
Search for other papers by Aneta Gawlik in
Google Scholar
PubMed
Search for other papers by Michael Shmoish in
Google Scholar
PubMed
Search for other papers by Michaela F Hartmann in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Search for other papers by Zbigniew Olczak in
Google Scholar
PubMed
Search for other papers by Katarzyna Gruszczynska in
Google Scholar
PubMed
Search for other papers by Ze’ev Hochberg in
Google Scholar
PubMed
there is possibility of multiple diagnoses or before starting therapy with potentially hepatotoxic medications’ ( 8 ). The consequences of obesity-related NAFLD on liver metabolism are insufficiently understood ( 8 ). As steroid hormones are partially
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alberto Sánchez-Guijo in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
Introduction Obesity is a complex condition associated with changes in many steroid hormones also including androgens: concentrations of testosterone and DHEAS and their precursors are increased in children ( 1 , 2 ) and obese women ( 3
Search for other papers by Willem de Ronde in
Google Scholar
PubMed
Search for other papers by Diederik L Smit in
Google Scholar
PubMed
Introduction Every now and then a clinical endocrinologist will be visited by a patient that uses anabolic androgenic steroids (AAS) or has been using them in the past. The interaction between doctor and patient may be hampered for a number of
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Henrik Ryberg in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Anna-Karin Norlén in
Google Scholar
PubMed
Sahlgrenska Osteoporosis Centre, Center for Bone and Arthritis Research (CBAR), Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Andreas Landin in
Google Scholar
PubMed
Search for other papers by Per Johansson in
Google Scholar
PubMed
Search for other papers by Zeinab Salman in
Google Scholar
PubMed
Search for other papers by Anders Wallin in
Google Scholar
PubMed
Department of Endocrinology, Skaraborg Central Hospital, Skövde, Sweden
Search for other papers by Johan Svensson in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Introduction Sex steroid hormones are predominantly produced from cholesterol by the gonads and the adrenal glands. Then, the sex steroids are distributed to target tissues through the circulation. In addition, many tissues and organs
Search for other papers by Sandra R Dahl in
Google Scholar
PubMed
Division of Medicine, Akershus University Hospital, Lørenskog, Norway
Search for other papers by Ingrid Nermoen in
Google Scholar
PubMed
Department of Clinical Medicine, University of Bergen, Bergen, Norway
Search for other papers by Ingeborg Brønstad in
Google Scholar
PubMed
K.G. Jebsen-Center for Autoimmune Diseases, University of Bergen, Bergen, Norway
Department of Medicine, Haukeland University Hospital, Bergen, Norway
Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
K.G. Jebsen-Center for Autoimmune Diseases, University of Bergen, Bergen, Norway
Department of Medicine, Haukeland University Hospital, Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
Search for other papers by Per M Thorsby in
Google Scholar
PubMed
assessment is not sensitive enough to identify subtle over- and under-treatment. Assay of the intermediates 17-hydroxyprogesterone (17OHP) and androstenedione is often used, but results are often difficult to interpret as cross-reactivity between steroids
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Search for other papers by Juliane Rothermel in
Google Scholar
PubMed
Search for other papers by Caroline Knop-Schmenn in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Christina Bosse in
Google Scholar
PubMed
Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
underlying mechanisms of PCOS are not fully understood yet though obesity and insulin resistance are regarded as major risk factors for hyperandrogenism in PCOS due to abnormal sex steroid production in ovaries and adrenals ( 2 ). Especially, the differential
Search for other papers by María J Gómora in
Google Scholar
PubMed
Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed
Search for other papers by Enrique Pedernera in
Google Scholar
PubMed
Search for other papers by Delia Perez-Montiel in
Google Scholar
PubMed
Search for other papers by Horacio López-Basave in
Google Scholar
PubMed
Search for other papers by Antonio R Villa in
Google Scholar
PubMed
Search for other papers by Azucena Hernández-Martínez in
Google Scholar
PubMed
Search for other papers by Esteban Mena in
Google Scholar
PubMed
Search for other papers by Carmen Mendez in
Google Scholar
PubMed
that can increase the incidence as well as tumor aggressiveness ( 8 , 9 , 10 ). Sexual steroid hormones acting through their receptors regulate signaling pathways related to cell proliferation, epithelial–mesenchymal transition, apoptosis, cell
Search for other papers by L Ghataore in
Google Scholar
PubMed
Search for other papers by I Chakraborti in
Google Scholar
PubMed
Search for other papers by S J Aylwin in
Google Scholar
PubMed
Search for other papers by K-M Schulte in
Google Scholar
PubMed
Departments of, Clinical Biochemistry, Medicine, Department of Endocrinology and Internal Medicine, King's College Hospital, London SE5 9RS, UK
Search for other papers by D Dworakowska in
Google Scholar
PubMed
Search for other papers by P Coskeran in
Google Scholar
PubMed
Search for other papers by N F Taylor in
Google Scholar
PubMed
in widespread use since publication in 2007 of the large retrospective study of Terzolo et al . (3) . Accumulated knowledge of the mode of action of mitotane together with its effects on steroid synthesis and catabolism is patchy. Mitotane targets